Next generation sequencing and array-based comparative genomic hybridization for molecular diagnosis of pediatric endocrine disorders

키워드

참고문헌 (47)

1. Lee C, "Copy number variations and clinical cytogenetic diagnosis of constitutional disorders", Nat Genet, 39(7 Suppl), pp.S48~S54 (2007)
2. Buonocore F, "Human sex development: targeted technologies to improve diagnosis", Genome Biol, 17, pp.257~ (2016)
3. Eggers S, "Disorders of sex development: insights from targeted gene sequencing of a large international patient cohort", Genome Biol, 17, pp.243~ (2016)
4. Burke W, "Genetic testing", N Engl J Med, 347, pp.1867~1875 (2002)
5. Katsanis SH, "Molecular genetic testing and the future of clinical genomics", Nat Rev Genet, 14, pp.415~426 (2013)
6. Smith DR, "Rapid whole-genome mutational profiling using next-generation sequencing technologies", Genome Res, 18, pp.1638~1642 (2008)
7. Shendure J, "Next-generation DNA sequencing", Nat Biotechnol, 26, pp.1135~1145 (2008)
8. Metzker ML, "Sequencing technologies: the next generation", Nat Rev Genet, 11, pp.31~46 (2010)
9. Pinkel D, "High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays", Nat Genet, 20, pp.207~211 (1998)
10. Vissers LE, "Array-based comparative genomic hybridization for the genomewide detection of submicroscopic chromosomal abnormalities", Am J Hum Genet, 73, pp.1261~1270 (2003)
11. Feuk L, "Structural variation in the human genome", Nat Rev Genet, 7, pp.85~97 (2006)
12. Miller DT, "Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies", Am J Hum Genet, 86, pp.749~764 (2010)
13. Izumi Y, "Genome-wide copy number analysis and systematic mutation screening in 58 patients with hypogonadotropic hypogonadism", Fertil Steril, 102, pp.1130~1136.e3 (2014)
14. Katoh-Fukui Y, "Testicular dysgenesis", regression without campomelic dysplasia in patients carrying missense mutations and upstream deletion of SOX9, 2015, pp.3, 550~557
15. Kon M, "Molecular basis of non-syndromic hypospadias: systematic mutation screening and genome-wide copynumber analysis of 62 patients", Hum Reprod, 30, pp.499~506 (2015)
16. Maki Fukami, "Paradoxical gain-of-function mutant of the G-protein-coupled receptor PROKR2 promotes early puberty", Journal of Cellular and Molecular Medicine, 21(10), pp.2623~2626 (2017), Wiley-Blackwell[DOI]
17. Alatzoglou KS, "Increased transactivation associated with SOX3 polyalanine tract deletion in a patient with hypopituitarism", J Clin Endocrinol Metab, 96, pp.E685~E690 (2011)
18. Kim HG, "WDR11, a WD protein that interacts with transcription factor EMX1, is mutated in idiopathic hypogonadotropic hypogonadism and Kallmann syndrome", Am J Hum Genet, 87, pp.465~479 (2010)
19. Bamshad MJ, "Exome sequencing as a tool for Mendelian disease gene discovery", Nat Rev Genet, 12, pp.745~755 (2011)
20. Abreu AP, "Central precocious puberty caused by mutations in the imprinted gene MKRN3", N Engl J Med, 368, pp.2467~2475 (2013)
21. Settas N, "Central precocious puberty in a girl and early puberty in her brother caused by a novel mutation in the MKRN3 gene", J Clin Endocrinol Metab, 99, pp.E647~E651 (2014)
22. Young Lim Shin, "An update on the genetic causes of central precocious puberty", Annals of Pediatirc Endocrinology & Metabolism, 21(2), pp.66~69 (2016), 대한소아내분비학회
23. Christoforidis A, "A novel MKRN3 nonsense mutation causing familial central precocious puberty", Endocrine, 56, pp.446~449 (2017)
24. Bashamboo A, "A recurrent p.Arg92Trp variant in steroidogenic factor-1 (NR5A1) can act as a molecular switch in human sex development", Hum Mol Genet, 25, pp.3446~3453 (2016)
25. Baetens D, "NR5A1 is a novel disease gene for 46,XX testicular and ovotesticular disorders of sex development", Genet Med, 19, pp.367~376 (2017)
26. Igarashi M, "Identical NR5A1 missense mutations in two unrelated 46,XX individuals with testicular tissues", Hum Mutat, 38, pp.39~42 (2017)
27. Miyado M, "The p.R92W variant of NR5A1", Nr5a1 induces testicular development of 46,XX gonads in humans, but not in mice: phenotypic comparison of human patients and mutation-induced mice, 2016, pp.7, 56~
28. Beckmann JS, "Copy number variants and genetic traits: closer to the resolution of phenotypic to genotypic variability", Nat Rev Genet, 8, pp.639~646 (2007)
29. Igarashi M, "Cryptic genomic rearrangements in three patients with 46,XY disorders of sex development", PLoS One, 8, pp.e68194~ (2013)
30. Fukami M, "Rare pseudoautosomal copy-number variations involving SHOX and", or its flanking regions in individuals with and without short stature, 2015, pp.60, 553~556
31. Fukami M, "SHOX haploinsufficiency as a cause of syndromic and nonsyndromic short stature", Mol Syndromol, 7, pp.3~11 (2016)
32. Shima H, "Systematic molecular analyses of SHOX in Japanese patients with idiopathic short stature and Leri- Weill dyschondrosteosis", J Hum Genet, 61, pp.585~591 (2016)
33. Benito-Sanz S, "Clinical and molecular evaluation of SHOX", PAR1 duplications in Leri-Weill dyschondrosteosis (LWD) and idiopathic short stature (ISS), 2011, pp.96, E404~E412
34. Benito-Sanz S, "Identification of the first recurrent PAR1 deletion in Léri-Weill dyschondrosteosis and idiopathic short stature reveals the presence of a novel SHOX enhancer", J Med Genet, 49, pp.442~450 (2012)
35. Fukami M, "Transactivation function of an approximately 800-bp evolutionarily conserved sequence at the SHOX 3' region: implication for the downstream enhancer", Am J Hum Genet, 78, pp.167~170 (2006)
36. Fukami M, "Aromatase excess syndrome: identification of cryptic duplications and deletions leading to gain of function of CYP19A1 and assessment of phenotypic determinants", J Clin Endocrinol Metab, 96, pp.E1035~E1043 (2011)
37. Fukami M, "Genomic basis of aromatase excess syndrome: recombination- and replication-mediated rearrangements leading to CYP19A1 overexpression", J Clin Endocrinol Metab, 98, pp.E2013~E2021 (2013)
38. Fukami M, "Aromatase excess syndrome: a rare autosomal dominant disorder leading to pre- or peri-pubertal onset gynecomastia", Pediatr Endocrinol Rev, 11, pp.298~305 (2014)
39. Shihara D, "Aromatase excess syndrome in a family with upstream deletion of CYP19A1", Clin Endocrinol (Oxf), 81, pp.314~316 (2014)
40. Vasli N, "Next generation sequencing for molecular diagnosis of neuromuscular diseases", Acta Neuropathol, 124, pp.273~283 (2012)
41. Green RC, "ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing", Genet Med, 15, pp.565~574 (2013)
42. Richards S, "Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology", Genet Med, 17, pp.405~424 (2015)
43. Matthijs G, "Guidelines for diagnostic next-generation sequencing", Eur J Hum Genet, 24, pp.2~5 (2016)
44. Wapner RJ, "Chromosomal microarray versus karyotyping for prenatal diagnosis", N Engl J Med, 367, pp.2175~2184 (2012)
45. Benn P, "Non-invasive prenatal testing for aneuploidy: current status and future prospects", Ultrasound Obstet Gynecol, 42, pp.15~33 (2013)
46. Marrs T, "The role of skin and gut microbiota in the development of atopic eczema", Br J Dermatol, 175(Suppl 2), pp.13~18 (2016)
47. Ma L, "Responses of earthworms and microbial communities in their guts to Triclosan", Chemosphere, 168, pp.1194~1202 (2017)

관련 논문AI추천